Tag: Hydromorphone
Ask the Experts: Opiates vs. opioids
In the midst of our nation’s opioid crisis, many people are confused about the difference between the term opiates and opioids. The media uses the words interchangeably; however there are significant distinctions between the two terms. Continue reading
Ask the Experts: DOT 5-panel drug test regimen
If you do the math, the DOT 5-panel drug test regimen requires confirmation testing for a total of 14 drugs. Is there a new name for the DOT drug test with the 2018 regulations? Continue reading
Staying compliant with new DOT regulations
New DOT regulations add four opioids: hydrocodone, oxycodone, hydromorphone, and oxymorphone to the test panel. Our experts answer your questions. Continue reading
Clarifying the changes in federal workplace drug testing & documentation
Changes to the federal drug testing panel and paperwork are forthcoming, but for now you should continue testing as usual. Continue reading
DEA proposal to curb production of prescription drugs
On August 7, 2017 the DEA published a proposal to limit the manufacturing of several controlled substances starting in 2018. Continue reading
Revisions to Federal workplace drug testing
HHS revised its mandatory guidelines to expand federal urine drug testing to include hydrocodone, hydromorphone, oxycodone, and oxymorphone. Continue reading
Drug testing trends video
A new video highlights key findings from the “Drug Testing Trends” session presented by Dr. Barry Sample at the annual DATIA conference. Watch now. Continue reading
Workplace opioid use is costing employers
A Wall Street Journal article highlights the impact of employees' heroin and opioids use in the workplace, citing recent Drug Testing Index data. Continue reading